149 related articles for article (PubMed ID: 2988468)
1. Interference of enantiomers of lofexidine with alpha-adrenoceptors.
Wilffert B; Mathy MJ; Batink HD; de Jonge A; Thoolen MJ; Prop G; Graf E; Timmermans PB; van Zwieten PA
Arch Int Pharmacodyn Ther; 1985 Jan; 273(1):18-32. PubMed ID: 2988468
[TBL] [Abstract][Full Text] [Related]
2. Binding of (+/-)-3H-lofexidine to alpha-adrenoceptors in membranes from rat brain.
Timmermans PB; van Kemenade JE; Harms YM; Prop G; Graf E; van Zwieten PA
Arch Int Pharmacodyn Ther; 1983 Jan; 261(1):23-35. PubMed ID: 6303236
[TBL] [Abstract][Full Text] [Related]
3. Pharmacological characterization of alpha adrenoceptors involved in the antinociceptive and cardiovascular effects of intrathecally administered clonidine.
Solomon RE; Brody MJ; Gebhart GF
J Pharmacol Exp Ther; 1989 Oct; 251(1):27-38. PubMed ID: 2571720
[TBL] [Abstract][Full Text] [Related]
4. Central alpha-2 adrenoceptor-mediated hypertensive response to clonidine in conscious, normotensive rats.
Kawasaki H; Takasaki K
J Pharmacol Exp Ther; 1986 Mar; 236(3):810-8. PubMed ID: 3005557
[TBL] [Abstract][Full Text] [Related]
5. Antihypertensive activity and interaction with alpha-adrenoceptors of tibalosine ([1-(2, 3-dihydro-5-benzo-(b)-thienyl)-2-(4-phenyl-butylamino)-1-propanol], CP 804 S) in rat and cat preparations.
Qian JQ; Mathy MJ; Thoolen MJ; Timmermans PB; van Zwieten PA
Arch Int Pharmacodyn Ther; 1983 Dec; 266(2):264-81. PubMed ID: 6141776
[TBL] [Abstract][Full Text] [Related]
6. Functional and biochemical evidence for the lack of cardiac presynaptic alpha-2 adrenoceptor stimulant properties of cirazoline (LD 3098), a potent alpha-1 adrenoceptor agonist in dogs and rats.
Cavero I; Lefèvre-Borg F; Roach AG; Gomeni R; Scatton B
J Pharmacol Exp Ther; 1982 Oct; 223(1):241-50. PubMed ID: 6126583
[TBL] [Abstract][Full Text] [Related]
7. Stereoselective blockade of alpha-adrenoceptors by berbine derivatives.
Schott C; Tetsi L; Heitz C; Stambach JF; Jung L; Stoclet JC
Arzneimittelforschung; 1988 Nov; 38(11):1567-71. PubMed ID: 2905599
[TBL] [Abstract][Full Text] [Related]
8. Cardiovascular effects and interaction with adrenoceptors of urapidil.
van Zwieten PA; de Jonge A; Wilffert B; Timmermans PB; Beckeringh JJ; Thoolen MJ
Arch Int Pharmacodyn Ther; 1985 Aug; 276(2):180-201. PubMed ID: 4051641
[TBL] [Abstract][Full Text] [Related]
9. Re-evaluation of the selectivity of 2-N,N-dimethylamino-5,6-dihydroxy-1,2,3, 4-tetrahydronaphthalene (M-7) as an agonist of postjunctional alpha-2 adrenoceptors in the pithed normotensive rat.
Timmermans PB; Wilffert B; Davidesko D; Mathy MJ; Dijkstra D; Horn AS; van Zwieten PA
J Pharmacol Exp Ther; 1983 May; 225(2):407-9. PubMed ID: 6132992
[TBL] [Abstract][Full Text] [Related]
10. Sgd 101/75: cardiovascular effects in various animal preparations; interactions with vascular postjunctional alpha 1- and alpha 2-adrenoceptors.
Mathy MJ; Thoolen MJ; Timmermans PB; van Zwieten PA
Br J Pharmacol; 1984 Feb; 81(2):255-62. PubMed ID: 6142740
[TBL] [Abstract][Full Text] [Related]
11. Urethane inhibits cardiovascular responses mediated by the stimulation of alpha-2 adrenoceptors in the rat.
Armstrong JM; Lefèvre-Borg F; Scatton B; Cavero I
J Pharmacol Exp Ther; 1982 Nov; 223(2):524-35. PubMed ID: 6127404
[TBL] [Abstract][Full Text] [Related]
12. Effect of aromatic fluorine substitution on the alpha and beta adrenoceptor-mediated effects of 3,4-dihydroxytolazoline in the pithed rat.
Nichols AJ; Hamada A; Adejare A; Miller DD; Patil PN; Ruffolo RR
J Pharmacol Exp Ther; 1989 Feb; 248(2):671-6. PubMed ID: 2537407
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of the alpha-1 and alpha-2 adrenoceptor-mediated effects of a series of dimethoxy-substituted tolazoline derivatives in the cardiovascular system of the pithed rat.
Ruffolo RR; Messick K
J Pharmacol Exp Ther; 1985 Jan; 232(1):94-9. PubMed ID: 2981322
[TBL] [Abstract][Full Text] [Related]
14. Selectivity of raubasine stereoisomers for alpha 1- and alpha 2-adrenoceptors in the rat.
Roquebert J
Arch Int Pharmacodyn Ther; 1986 Aug; 282(2):252-61. PubMed ID: 3021076
[TBL] [Abstract][Full Text] [Related]
15. Pre- and postsynaptic alpha adrenoceptor selectivity studies with yohimbine and its two diastereoisomers rauwolscine and corynanthine in the anesthetized dog.
Shepperson NB; Duval N; Massingham R; Langer SZ
J Pharmacol Exp Ther; 1981 Nov; 219(2):540-6. PubMed ID: 6270312
[TBL] [Abstract][Full Text] [Related]
16. Increased alpha 1- and decreased alpha 2-adrenoceptor sensitivities upon chronic treatment with imipramine in mediating cardiovascular responses in pithed rats.
Rhim BY; Jung HO; Yu DH; Hong KW
Arch Int Pharmacodyn Ther; 1987 Nov; 290(1):77-91. PubMed ID: 2895612
[TBL] [Abstract][Full Text] [Related]
17. Differential blocking effects of prazosin and yohimbine on vasopressor responses to sympathetic nerve stimulation and intravenous norepinephrine in the pithed rat.
Lee JY; Walsh GM; Heilman RD; Radzialowski FM
Res Commun Chem Pathol Pharmacol; 1984 Jan; 43(1):97-112. PubMed ID: 6322258
[TBL] [Abstract][Full Text] [Related]
18. Animal experiments on the cardiovascular effects of lofexidine.
Graf E; Doppelfeld IS; Prop G
Arzneimittelforschung; 1982; 32(8a):941-55. PubMed ID: 6890368
[TBL] [Abstract][Full Text] [Related]
19. Evidence for central alpha 2-adrenoceptor-mediated hypertension in freely moving, normotensive rats.
Kawasaki H; Takasaki K
Arch Int Pharmacodyn Ther; 1987 Oct; 289(2):217-33. PubMed ID: 2892472
[TBL] [Abstract][Full Text] [Related]
20. A study of the selectivity and potency of rauwolscine, RX 781094 and RS 21361 as antagonists of alpha-1 and alpha-2 adrenoceptors.
Timmermans PB; Qian JQ; Ruffolo RR; van Zwieten PA
J Pharmacol Exp Ther; 1984 Mar; 228(3):739-48. PubMed ID: 6142941
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
